International Journal of Scientific and Research Publications

About Us
Editorial Board

Online Publication

Review Process
Publication Ethics

Call For Papers

Call for Research Paper


Online Submission
Paper Submission Guidelines
Online Publication Charge
Print Publication Charge
How to publish research paper
Publication Certificate
Research Catalogue


Join Reviewer Panel
Reviewer Guidelines

IJSRP Publications

Print Journal


IJSRP Paper Format

Contact Us

Feedback Form
Contact Us
Site Map

IJSRP, Volume 10, Issue 11, November 2020 Edition [ISSN 2250-3153]

      Dina Saeed Solitah, Mustafa Ashraf Salah

Abstract: Cancer is one of the most challenging diseases and up until now. One of the most challenging things about cancer treatment is not the cure itself but the differentiation between the tumor cells and the normal cells. Most of the medical treatments of the cancer today cannot differentiate between the cancer cells and the normal one as well as it damages the hall tissue and it is still considered as a low-effect treatment to be applied in cancer. One of the most popular treatments of this kind is chemotherapy which is known for damaging the hall cells, cancer, and normal ones.

[Reference this Paper]   [BACK]

Ooops! It appears you don't have a PDF plugin for this barrPostingser. you can click here to download the PDF file.

Reference this Research Paper (copy & paste below code):

Dina Saeed Solitah, Mustafa Ashraf Salah (2020); The effect of using the monoclonal antibodies of the protein ErbB-2 antigen on the lung cancer patients; International Journal of Scientific and Research Publications (IJSRP) 10(11) (ISSN: 2250-3153), DOI:



About Us
Editorial Board
Call for Paper

Call for Research Paper
Paper Status
IJSRP Paper Format
Join Us

Download e-journal
Join Forum
Invite Friends
Get Social with Us!

Copyright © 2011-2021, IJSRP Inc., All rights reserved.